Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: Insights from the NCDR PINNACLE registry

Journal of the American College of Cardiology

Volumn 64, Issue 21, 2014, Pages 2183-2192

  Maddox, Thomas M ^a,b   Borden, William B ^c   Tang, Fengming ^d   Virani, Salim S ^e   Oetgen, William J ^f   Mullen, J Brendan ^g   Chan, Paul S ^d   Casale, Paul N ^h   Douglas, Pamela S ⁱ   Masoudi, Fredrick A ^a,b   Farmer, Steven A ^c   Rumsfeld, John S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^g NATIONAL QUALITY FORUM   (United States)

^h Penn Medicine Lancaster General Health Physicians Geriatrics   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cardiovascular diseases; cholesterol; cohort studies; hydroxymethylglutaryl coA reductase inhibitors; primary prevention; secondary prevention

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INDICATION; DRUG USE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MIDDLE AGED; PATIENT ASSESSMENT; PATIENT IDENTIFICATION; PATIENT SELECTION; PRACTICE GUIDELINE; RISK FACTOR; UNITED STATES; BLOOD; CORONARY ARTERY DISEASE; HYPERCHOLESTEROLEMIA; REGISTER; RISK ASSESSMENT;

ADULT; AGED; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RISK ASSESSMENT; UNITED STATES;

EID: 84921670737     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.08.041     Document Type: Article

References (13)

1. N.J. Stone, J.G. Robinson, A.H. Lichtenstein for the American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2889 2934
2. G.H. Gibbons, S.B. Shurin, G.A. Mensah, and M.S. Lauer Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute J Am Coll Cardiol 62 2013 1396 1398
3. G.H. Gibbons, J.G. Harold, M. Jessup, R.M. Robertson, and W.J. Oetgen The next steps in developing clinical practice guidelines for prevention J Am Coll Cardiol 62 2013 1399 1400
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
5. Eden J, Levit L, Berg A, et al., for the Institute of Medicine, editors. Finding What Works in Health Care: Standards for Systematic Reviews. Washington, DC: National Academies Press, 2011.
6. Graham R, Wolman DM, Greenfield S, et al., for the Institute of Medicine, editors. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press, 2011.
7. M.J. Pencina, A.M. Navar-Boggan, and R.B. D'Agostino Application of new cholesterol guidelines to a population-based sample N Engl J Med 370 2014 1422 1431
8. P.S. Chan, W.J. Oetgen, and J.A. Spertus The Improving Continuous Cardiac Care (IC(3)) program and outpatient quality improvement Am J Med 123 2010 217 219
9. J.C. Messenger, K.K. Ho, C.H. Young for the NCDR Science and Quality Oversight Committee Data Quality Workgroup The National Cardiovascular Data Registry (NCDR) Data Quality Brief: The NCDR Data Quality Program in 2012 J Am Coll Cardiol 60 2012 1484 1488
10. F.A. Masoudi, A. Ponirakis, and R.W. Yeh Cardiovascular care facts: a report from the National Cardiovascular Data Registry: 2011 J Am Coll Cardiol 62 2013 1931 1947
11. P.M. Ridker, and N.R. Cook Statins: new American guidelines for prevention of cardiovascular disease Lancet 382 2013 1762 1765
12. D.M. Lloyd-Jones, D. Goff, and N.J. Stone Statins, risk assessment, and the new American prevention guidelines Lancet 383 2014 600 602
13. F.C. Taylor, M. Huffman, and S. Ebrahim Statin therapy for primary prevention of cardiovascular disease JAMA 310 2013 2451 2452